9 Publikationen
-
2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2987695Krug, D., Vladimirova, V., Untch, M., Kühn, T., Schneeweiss, A., Denkert, C., Ataseven, B., et al. (2024). Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy. Breast , 74. https://doi.org/10.1016/j.breast.2024.103701
-
2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987540Herold, N., Schmolling, J., Ernst, C., Ataseven, B., Bluemcke, B., Schoemig-Markiefka, B., Heikaus, S., et al. (2024). Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Abstracts from the 56th European Society of Human Genetics (ESHG) Conference, European Journal of Human Genetics , 32, 548. London: Nature.
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2979534Imterat, M., Harter, P., Rhiem, K., Heitz, F., Schneider, S., Concin, N., Moubarak, M., et al. (2023). Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients. Cancers, 15(9), 2534. https://doi.org/10.3390/cancers15092534
-
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2985382Slomovitz, B. M., Raaschou-Jensen, N., Coleman, R. L., Gilbert, L., Powell, M. A., Cibula, D., Ghamande, S., et al. (2023). PFS2 and adjustment of overall survival (OS) for subsequent anticancer therapy in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab plus chemotherapy or chemotherapy alone in the ENGOT-EN3-NSGO/GOG-3031/RUBY trial. Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, Annals of Oncology , 34, S514-S515. Amsterdam: Elsevier. https://doi.org/10.1016/j.annonc.2023.09.1929
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984317Marme, F., Krieghoff-Henning, E., Gerber, B., Schmitt, M., Zahm, D. - M., Bauerschlag, D., Forstbauer, H., et al. (2023). Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological images. European Journal of Cancer, 195, 113390. https://doi.org/10.1016/j.ejca.2023.113390
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984002Imterat, M., Gebers, G., Heitz, F., Schneider, S., Ehmann, S., Welz, J., du Bois, A., et al. (2023). Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal study. Gynecologic Oncology, 178, 96-101. https://doi.org/10.1016/j.ygyno.2023.10.002
-
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984318Bizzarri, N., Imterat, M., Fruscio, R., Giannarelli, D., Perrone, A. M., Mancari, R., Traut, A., et al. (2023). Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth? European Journal of Cancer, 195, 113398. https://doi.org/10.1016/j.ejca.2023.113398
-
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2980959Herold, N., Schmolling, J., Ernst, C., Ataseven, B., Blümcke, B., Schömig-Markiefka, B., Heikaus, S., et al. (2023). Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine . https://doi.org/10.1002/cam4.6214
-
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2979540Inci, M. G., Sehouli, J., Schnura, E., Lee, M., Roll, S., Reinhold, T., Klews, J., et al. (2023). The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design. International Journal of Gynecological Cancer , ijgc-2023-004531. https://doi.org/10.1136/ijgc-2023-004531